Dynacare is committed to aligning test offerings with current gold-standard analytical techniques to support quality patient care. Effective June 19th, Dynacare will be changing the testing methodology for Phenobarbital, Primidone, and Ethosuximide.
Read More - Change in Methodology for Anti-Epileptic Drug Testing: Phenobarbital, Primidone, and Ethosuximide (ON and QC)